Acorda Therapeutics traded at $0.47 this Friday July 1st, increasing $0.004 or 0.86 percent since the previous trading session. Looking back, over the last four weeks, Acorda Therapeutics gained 7.72 percent. Over the last 12 months, its price fell by 89.83 percent. Looking ahead, we forecast Acorda Therapeutics to be priced at 0.51 by the end of this quarter and at 0.47 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
0.47
Daily Change
0.86%
Yearly
-89.83%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Acadia Pharmaceuticals 14.23 0.14 0.99% -42.55%
Acorda Therapeutics 0.47 0.004 0.86% -89.83%
Agios Pharmaceuticals 22.17 -0.21 -0.94% -60.71%
ALKERMES 29.77 -0.02 -0.07% 19.56%
Amgen 243.10 -0.20 -0.08% -2.25%
Anika Therapeutics 22.32 -0.19 -0.84% -49.81%
Aptinyx Inc 0.56 0.002 0.38% -80.56%
Arrowhead Research 35.21 0.65 1.88% -58.56%
Biogen 206.02 2.08 1.02% -40.92%
BioMarin Pharmaceutical 82.87 -1.05 -1.25% -1.24%
Cara Therapeutics 9.13 -0.47 -4.90% -36.82%
Clovis Oncology 1.80 0.09 5.26% -68.97%
Cytokinetics 42.05 2.76 7.01% 100.41%
Enanta Pharmaceuticals 47.26 -0.01 -0.02% 5.73%
Gilead Sciences 61.73 -0.08 -0.13% -10.92%
GlaxoSmithKline 1,776.60 11.00 0.62% 23.56%
Halozyme Therapeutics 44.16 0.16 0.36% -4.75%
Heron Therapeutics 2.69 -0.11 -3.76% -82.10%
Insmed 19.88 0.16 0.81% -32.54%
Ligand Pharmaceuticals 89.43 0.21 0.24% -34.21%
MannKind 3.88 0.07 1.84% -29.20%
Merck 165.50 4.50 2.80% 1.66%
Moderna Inc 149.97 7.12 4.98% -36.21%
Neurocrine Biosciences 98.41 0.93 0.95% 0.97%
Novartis 80.34 -0.51 -0.63% -4.95%
Pfizer 51.47 -0.96 -1.83% 29.55%
Ultragenyx Pharmaceutical 61.56 1.90 3.18% -34.66%
Sanofi 97.35 1.01 1.05% 10.75%
Teva Pharmaceutical Industries Ltd 2,670.00 -83.00 -3.01% -18.10%
Vertex Pharmaceuticals 284.22 2.43 0.86% 41.73%

Indexes Price Day Year
USND 10975 -53.55 -0.49% -25.03%

Acorda Therapeutics
Acorda Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on developing therapies that restore function and improve the lives of people with neurological disorders. Its ARCUS pulmonary delivery system, a technology platform designed to deliver medication through inhalation is used in the development of variety of inhaled medicines. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), Fampyra (fampridine) and Selincro (nalmefene). It markets Inbrija for intermittent treatment of off episodes, also known as off periods, in people with Parkinson's disease treated with carbidopa/levodopa. Ampyra is a drug to improve walking in adults with multiple sclerosis. Its product pipelines includes ARCUS for acute migraine, Cimaglermin alfa for heart failure and rHIgM22 for multiple sclerosis.